RASSF1A Mediates P21Cip1/Waf1-Dependent Cell Cycle Arrest and Senescence Through Modulation of the Raf-Mek-Erk Pathway and Inhibition of Akt

Cancer Research - United States
doi 10.1158/0008-5472.can-08-1377
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Modulation of the Akt/Ras/Raf/Mek/Erk Pathway by A3 Adenosine Receptor

Purinergic Signalling
Molecular NeuroscienceCell BiologyMolecular BiologyCellular
2006English

Bicyclol Induces Cell Cycle Arrest and Autophagy in HepG2 Human Hepatocellular Carcinoma Cells Through the PI3K/AKT and Ras/Raf/Mek/Erk Pathways

BMC Cancer
Cancer ResearchOncologyGenetics
2016English

Anticancer Activity of Sugiol Against Ovarian Cancer Cell Line SKOV3 Involves Mitochondrial Apoptosis, Cell Cycle Arrest and Blocking of the RAF/MEK/ERK Signalling Pathway

Archives of Medical Science
Medicine
2020English

Prohibitins Role in Cellular Survival Through Ras-Raf-Mek-Erk Pathway

Journal of Cellular Physiology
Clinical BiochemistryCell BiologyPhysiology
2014English

Norcantharidin Induces Growth Inhibition and Apoptosis of Glioma Cells by Blocking the Raf/Mek/Erk Pathway

World Journal of Surgical Oncology
SurgeryOncology
2014English

Fractalkine Stimulates Angiogenesis by Activating the Raf-1/Mek/Erk- And PI3K/Akt/eNOS-dependent Signal Pathways

American Journal of Physiology - Heart and Circulatory Physiology
Cardiovascular MedicinePhysiologyCardiology
2006English

Targeting the Ras/Raf/Mek/Erk Pathway in Hepatocellular Carcinoma (Review)

Oncology Letters
Cancer ResearchOncology
2017English

Astragaloside IV Attenuates Glutamate-Induced Neurotoxicity in PC12 Cells Through Raf-Mek-Erk Pathway

PLoS ONE
Multidisciplinary
2015English

Correction: Amphiregulin Enhances Alpha6beta1 Integrin Expression and Cell Motility in Human Chondrosarcoma Cells Through Ras/Raf/Mek/Erk/Ap-1 Pathway

Oncotarget
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy